AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
Minichromosome maintenance protein 2 expression in prostate: Characterization and association with outcome after therapy for cancer
Authors: Meng, MV Grossfeld, GD Williams, GH Dilworth, S Stoeber, K Mulley, TW Weinberg, V Carroll, PR Tlsty, TD
Citation: Mv. Meng et al., Minichromosome maintenance protein 2 expression in prostate: Characterization and association with outcome after therapy for cancer, CLIN CANC R, 7(9), 2001, pp. 2712-2718
Prostate cancer early detection: a clinical perspective
Authors: Grossfeld, GD Carroll, PR
Citation: Gd. Grossfeld et Pr. Carroll, Prostate cancer early detection: a clinical perspective, EPIDEMIOL R, 23(1), 2001, pp. 173-180
Overview consensus statement
Authors: Carroll, PR Fair, WR Grossfeld, GD Heston, WDW Lieberman, R Malkowicz, SB Stricker, HJ Sylvester, J Peehl, DM Meyer, F Hart, C
Citation: Pr. Carroll et al., Overview consensus statement, UROLOGY, 58(2A), 2001, pp. 1-4
Androgen deprivation therapy for patients with clinically localized (stages T1 to T3) prostate cancer and for patients with biochemical recurrence after radical prostatectomy
Authors: Grossfeld, GD Small, EJ Lubeck, DP Latini, D Broering, JM Carroll, PR
Citation: Gd. Grossfeld et al., Androgen deprivation therapy for patients with clinically localized (stages T1 to T3) prostate cancer and for patients with biochemical recurrence after radical prostatectomy, UROLOGY, 58(2A), 2001, pp. 56-64
Discussion following Dr. Gary D. Grossfeld's presentation
Authors: Trachtenberg, J Grossfeld, GD Lubeck, DP Bubley, GJ Carroll, PR Fair, WR Newling, DWW
Citation: J. Trachtenberg et al., Discussion following Dr. Gary D. Grossfeld's presentation, UROLOGY, 58(2A), 2001, pp. 64-64
The effect of androgen deprivation therapy on health-related quality of life in men with prostate cancer
Authors: Lubeck, DP Grossfeld, GD Carroll, PR
Citation: Dp. Lubeck et al., The effect of androgen deprivation therapy on health-related quality of life in men with prostate cancer, UROLOGY, 58(2A), 2001, pp. 94-99
Intermittent androgen deprivation: Update of cycling characteristics in patients without clinically apparent metastatic prostate cancer
Authors: Grossfeld, GD Chaudhary, UB Reese, DM Carroll, PR Small, EJ
Citation: Gd. Grossfeld et al., Intermittent androgen deprivation: Update of cycling characteristics in patients without clinically apparent metastatic prostate cancer, UROLOGY, 58(2), 2001, pp. 240-245
Evaluation of asymptomatic microscopic hematuria in adults: The American Urological Association Best Practice Policy - Part I: Definition, detection,prevalence, and etiology
Authors: Grossfeld, GD Litwin, MS Wolf, JS Hricak, H Shuler, CL Agerter, DC Carroll, PR
Citation: Gd. Grossfeld et al., Evaluation of asymptomatic microscopic hematuria in adults: The American Urological Association Best Practice Policy - Part I: Definition, detection,prevalence, and etiology, UROLOGY, 57(4), 2001, pp. 599-603
Evaluation of asymptomatic microscopic hematuria in adults: The American Urological Association Best Practice Policy - Part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up
Authors: Grossfeld, GD Litwin, MS Wolf, JS Hricak, H Shuler, CL Agerter, DC Carroll, PR
Citation: Gd. Grossfeld et al., Evaluation of asymptomatic microscopic hematuria in adults: The American Urological Association Best Practice Policy - Part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up, UROLOGY, 57(4), 2001, pp. 604-610
Prostate sampling to predict radical prostatectomy outcome - Reply
Authors: Grossfeld, GD
Citation: Gd. Grossfeld, Prostate sampling to predict radical prostatectomy outcome - Reply, UROLOGY, 57(2), 2001, pp. 394-395
Extramammary Paget's disease of the penis and scrotum: Excision, reconstruction and evaluation of occult malignancy
Authors: Park, S Grossfeld, GD McAninch, JW Santucci, R
Citation: S. Park et al., Extramammary Paget's disease of the penis and scrotum: Excision, reconstruction and evaluation of occult malignancy, J UROL, 166(6), 2001, pp. 2112-2116
Predicting risk of prostate specific antigen recurrence after radical prostatectomy with the center for prostate disease research and cancer of the prostate strategic urologic research endeavor databases
Authors: Moul, JW Connelly, RR Lubeck, DP Bauer, JJ Sun, L Flanders, SC Grossfeld, GD Carroll, PR
Citation: Jw. Moul et al., Predicting risk of prostate specific antigen recurrence after radical prostatectomy with the center for prostate disease research and cancer of the prostate strategic urologic research endeavor databases, J UROL, 166(4), 2001, pp. 1322-1327
Is anastomotic biopsy necessary before radiotherapy after radical prostatectomy?
Authors: Koppie, TM Grossfeld, GD Nudell, DM Weinberg, VK Carroll, PR
Citation: Tm. Koppie et al., Is anastomotic biopsy necessary before radiotherapy after radical prostatectomy?, J UROL, 166(1), 2001, pp. 111-115
Prostate cancer detection in men with prior high grade prostatic intraepithelial neoplasia or atypical prostate biopsy
Authors: Park, S Shinohara, K Grossfeld, GD Carroll, PR
Citation: S. Park et al., Prostate cancer detection in men with prior high grade prostatic intraepithelial neoplasia or atypical prostate biopsy, J UROL, 165(5), 2001, pp. 1409-1414
Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: Results from the Cancer of the Prostate Strategic Urologic Research Endeavor database
Authors: Grossfeld, GD Chang, JJ Broering, JM Li, JP Lubeck, DP Flanders, SC Carroll, PR
Citation: Gd. Grossfeld et al., Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: Results from the Cancer of the Prostate Strategic Urologic Research Endeavor database, J UROL, 165(3), 2001, pp. 851-856
Malignant transformation in a nontumorigenic human prostatic epithelial cell line
Authors: Hayward, SW Wang, YH Cao, M Hom, YK Zhang, BH Grossfeld, GD Sudilovsky, D Cunha, GR
Citation: Sw. Hayward et al., Malignant transformation in a nontumorigenic human prostatic epithelial cell line, CANCER RES, 61(22), 2001, pp. 8135-8142
The consequences of chromosomal aneuploidy on gene expression profiles in a cell line model for prostate carcinogenesis
Authors: Phillips, JL Hayward, SW Wang, YH Vasselli, J Pavlovich, C Padilla-Nash, H Pezullo, JR Ghadimi, BM Grossfeld, GD Rivera, A Linehan, WM Cunha, GR Ried, T
Citation: Jl. Phillips et al., The consequences of chromosomal aneuploidy on gene expression profiles in a cell line model for prostate carcinogenesis, CANCER RES, 61(22), 2001, pp. 8143-8149
Asymptomatic microscopic hematuria in adults: Summary of the AUA Best Practice Policy recommendations
Authors: Grossfeld, GD Wolf, JS Litwin, MS Hricak, H Shuler, CL Agerter, DC Carroll, PR
Citation: Gd. Grossfeld et al., Asymptomatic microscopic hematuria in adults: Summary of the AUA Best Practice Policy recommendations, AM FAM PHYS, 63(6), 2001, pp. 1145-1154
Additional treatments and reimbursement rates associated with prostate cancer treatment for patients undergoing radical prostatectomy, interstitial brachytherapy, and external beam radiotherapy
Authors: Goharderakhshan, RZ Grossfeld, GD Kassis, A Shinohara, K Roach, M Carroll, PR
Citation: Rz. Goharderakhshan et al., Additional treatments and reimbursement rates associated with prostate cancer treatment for patients undergoing radical prostatectomy, interstitial brachytherapy, and external beam radiotherapy, UROLOGY, 56(4), 2000, pp. 622-626
Does the completeness of prostate sampling predict outcome for patients undergoing radical prostatectomy?: Data from the CaPSURE database
Authors: Grossfeld, GD Chang, JJ Broering, JM Miller, DP Yu, J Flanders, SC Carroll, PR
Citation: Gd. Grossfeld et al., Does the completeness of prostate sampling predict outcome for patients undergoing radical prostatectomy?: Data from the CaPSURE database, UROLOGY, 56(3), 2000, pp. 430-435
Benign prostatic hyperplasia: Clinical overview and value of diagnostic imaging
Authors: Grossfeld, GD Coakley, FV
Citation: Gd. Grossfeld et Fv. Coakley, Benign prostatic hyperplasia: Clinical overview and value of diagnostic imaging, RAD CLIN NA, 38(1), 2000, pp. 31
The prostatic gland: Malignancies other than adenocarcinomas
Authors: Varghese, SL Grossfeld, GD
Citation: Sl. Varghese et Gd. Grossfeld, The prostatic gland: Malignancies other than adenocarcinomas, RAD CLIN NA, 38(1), 2000, pp. 179
Patterns of treatment of patients with prostate cancer initially managed with surveillance: Results from the CaPSURE database
Authors: Koppie, TM Grossfeld, GD Miller, D Yu, J Stier, D Broering, JM Lubeck, D Henning, JM Flanders, SC Carroll, PR
Citation: Tm. Koppie et al., Patterns of treatment of patients with prostate cancer initially managed with surveillance: Results from the CaPSURE database, J UROL, 164(1), 2000, pp. 81-88
Management of a positive surgical margin after radical prostatectomy: Decision analysis
Authors: Grossfeld, GD Tigrani, VS Nudell, D Roach, M Weinberg, VK Presti, JC Small, EJ Carroll, PR
Citation: Gd. Grossfeld et al., Management of a positive surgical margin after radical prostatectomy: Decision analysis, J UROL, 164(1), 2000, pp. 93-99
Management of a positive surgical margin after radical prostatectomy: Decision analysis - Reply
Authors: Grossfeld, GD Tigrani, VS Nudell, D Roach, M Weinberg, VK Presti, JC Small, EJ Carroll, PR
Citation: Gd. Grossfeld et al., Management of a positive surgical margin after radical prostatectomy: Decision analysis - Reply, J UROL, 164(1), 2000, pp. 100-100
Risultati: 1-25 | 26-30